Milestone Pharmaceuticals grants 288,000 inducement stock options at $1.32 per sharePUBT·Jul 2 at 08:30 PMMIST-6.64%
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | MIST Stock NewsStockTitan·Jul 2 at 12:30 PMMIST-6.64%
Milestone Pharmaceuticals (MIST) Gets a Buy from Piper SandlerTip Ranks·May 14 at 06:17 AMMIST-6.64%BBH+2.35%
Buy Rating Reiterated on Milestone as Cardamyst Traction Grows and AFib Program Advances; $8 Price Target UnchangedTip Ranks·May 13 at 04:05 PMMIST-6.64%IHE+1.00%
Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update | MIST Stock NewsStockTitan·May 12 at 10:11 PMMIST-6.64%IHE+1.00%
Milestone Pharmaceuticals Q1 2026 Earnings Call: Complete Transcriptbenzinga_article·May 13 at 08:40 AMMIST-6.64%FBT+1.63%
Sionna Therapeutics shares are trading lower after the company reported worse-than-expected Q1 EPS results.benzinga_article·May 12 at 10:17 AMSION+0.71%
